These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6668097)

  • 41. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation.
    Schechter T; Finkelstein Y; Doyle J; Verjee Z; Moretti M; Koren G; Dupuis LL
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):307-14. PubMed ID: 17317584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of prednisone on serum and urinary thyroid hormone levels in children during the nephrotic syndrome.
    Etling N; Fouque F
    Helv Paediatr Acta; 1982 Jun; 37(3):257-65. PubMed ID: 6811505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of albumin infusion upon plasma norepinephrine concentration in nephrotic children.
    Kelsch RC; Light GS; Oliver WJ
    J Lab Clin Med; 1972 Apr; 79(4):516-25. PubMed ID: 5021294
    [No Abstract]   [Full Text] [Related]  

  • 46. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
    Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disposition of furosemide in functionally hepatectomized dogs.
    Verbeeck RK; Gerkens JF; Wilkinson GR; Branch RA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):479-83. PubMed ID: 7205627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does albumin and furosemide therapy affect plasma volume in nephrotic children?
    Bircan Z; Kervancioğlu M; Katar S; Vitrinel A
    Pediatr Nephrol; 2001 Jun; 16(6):497-9. PubMed ID: 11420914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.
    Hsu CW; Lin SL; Sun SF; Chu KA; Chung HM; Chang HW
    J Nephrol; 2006; 19(5):621-7. PubMed ID: 17136691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of tienilic acid in nephrotic syndrome: a clinical study.
    Morgan A; Birch H; Lee HA
    Postgrad Med J; 1979; 55 Suppl 3():63-7. PubMed ID: 504041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
    González G; Arancibia A; Rivas MI; Caro P; Antezana C
    Eur J Clin Pharmacol; 1982; 22(4):315-20. PubMed ID: 7106167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of severe nephrotic edema with albumin and furosemide.
    Weiss RA; Schoeneman M; Greifer I
    N Y State J Med; 1984 Aug; 84(8):384-6. PubMed ID: 6592472
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cumulative increase in serum furosemide concentration following repeated doses in the newborn.
    Chemtob S; Papageorgiou A; du Souich P; Aranda JV
    Am J Perinatol; 1987 Jul; 4(3):203-5. PubMed ID: 3606754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of experimental nephrotic syndrome with artesunate.
    Razavi A; Nouri HR; Mehrabian F; Mirshafiey A
    Int J Toxicol; 2007; 26(4):373-80. PubMed ID: 17661229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma volume and effect of high dose frusemide in nephrotic syndrome.
    Wadehra DN; Kumar R; Gopinath PG
    J Assoc Physicians India; 1979 Oct; 27(10):955-8. PubMed ID: 541316
    [No Abstract]   [Full Text] [Related]  

  • 58. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.
    Green TP; Mirkin BL
    J Pharmacol Exp Ther; 1981 Jul; 218(1):122-7. PubMed ID: 7241373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.
    Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Forte M; Morachiello P
    Z Kardiol; 1985; 74 Suppl 2():92-5. PubMed ID: 4002811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.